On Tuesday, BioCryst Pharmaceuticals (Nasdaq: BCRX) announced that the National Institute of Allergy and Infectious Diseases (NIAID) has contracted with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE